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 BIRTH CHARACTERISTICS AND CHILDHOOD LEUKEMIA RISK: 
CORRELATIONS WITH GENETIC MARKERS 
 
Abstract  
Birth characteristics such as birth order, birth weight, birth defects, and Down syndrome 
showed some of the first risk associations with childhood leukemia. Examinations of correlations 
between birth characteristics and leukemia risk markers have been limited to birth weight-related 
genetic polymorphisms. We integrated information on non-genetic and genetic markers by 
evaluating the relationship of birth characteristics, genetic markers for childhood acute 
lymphoblastic leukemia (ALL) susceptibility, and ALL risk together. The multi-ethnic study 
consisted of cases with childhood ALL (n=161) and healthy controls (n=261). Birth 
characteristic data were collected through questionnaires, and genotyping was achieved by 
TaqMan® SNP Genotyping Assays. We observed risk associations for birth weight over 4,000 
grams (OR=1.93, 95% CI=1.16 to 3.19), birth length (OR=1.18 per inch, 95% CI=1.01 to 1.38), 
and with gestational age (OR=1.10 per week, 95% CI=1.00 to 1.21). Only the HFE tag SNP 
rs9366637 showed an inverse correlation with a birth characteristic, gestational age, with a gene-
dosage effect (P=0.005) and in interaction with a transferrin receptor rs3817672 genotype 
(Pinteraction=0.05). This correlation translated into a strong association for rs9366637 with preterm 
birth (OR=5.0, 95% CI=1.19 to 20.9). Our study provides evidence for the involvement of 
prenatal events in the development of childhood ALL. The inverse correlation of rs9366637 with 
gestational age has implications on the design of HFE association studies in birth weight and 
childhood conditions using full-term newborns as controls.  
 
 Introduction  
Birth order, birth weight, birth defects, and Down syndrome were among the first risk 
factors shown to be associated with childhood leukemia risk 
1-3
. Subsequent studies have 
established Down syndrome, increased birth weight, and several congenital disorders as 
consistent risk factors for childhood acute lymphoblastic leukemia (ALL) 
4, 5
. More limited data 
are available on the suggestive associations of being first-born, maternal age and miscarriages in 
maternal reproductive history with childhood ALL 
5
. Of these, only the molecular mechanism of 
Down syndrome association has been established 
6
. Birth weight shows a consistent positive 
association with childhood ALL that has been confirmed by meta-analyses 
7-9
. Several biological 
mechanisms for the birth weight association have been speculated 
10-12
, but none have been 
established firmly. 
Although a number of studies have examined the associations of birth characteristics with 
childhood ALL 
10, 13-20
 and adult cancer risk 
21
, few examined the correlations between genetic 
risk markers and birth characteristics, mainly birth weight 
22
. Those studies that did examine 
genetic risk factors used polymorphisms previously identified in genome-wide association 
studies (GWAS) and mostly yielded negative results. The importance of the examination of birth 
characteristics in childhood ALL research stems from recent evidence suggesting a prenatal 
origin for childhood ALL development 
23-26
, and more broadly the concept of developmental 
origins of health and disease 
27-29
.  
Our aim was to explore associations of birth characteristics with childhood ALL as well 
as their correlations with selected risk markers for childhood ALL to integrate information on 
non-genetic and genetic markers. We had data on birth weight, birth length, and gestational age, 
and we included a representative set of risk markers previously identified in GWAS, HLA region 
 markers due to the association of HLA region polymorphisms with birth weight 
30-33
, iron 
regulatory gene HFE polymorphisms previously shown to correlate with birth weight 
11
 and 
additional iron-regulatory genes for their potential associations with birth characteristics. Since 
our sample was multi-ethnic/racial, we also explored heterogeneity among non-Hispanic Whites 
and Hispanics in any association observed. 
Materials and Methods  
Subjects 
Institutional Review Board (IRB) approval was received at the Baylor College of 
Medicine (BCM) and Florida International University prior to the start of the research project. 
Subjects were recruited at Texas Children’s Hospitalin Houston, TX. The study was originally 
designed as a leukemia association study. The case-control group consisted of 161 incident 
childhood ALL cases and 231 healthy, age- and gender matched controls contemporaneously 
recruited at Texas Children’s Hospital general pediatric clinics. The children were less than 18 
years of age at diagnosis, and exclusion criteria for both groups included refusal to participate in 
the study and the diagnosis of any other cancer or other disease. Subjects and their parents were 
approached to acquire informed consent and epidemiological data with a questionnaire and a 
biological sample, thus the gestational age data was not record-based. DNA samples were 
obtained from either saliva or peripheral blood samples at Texas Children's Hospital. Parents 
were asked to provide information on race (White, Black/African American, Asian, American 
Indian/Alaska Native, or Native Hawaiian/Other Pacific Islander) and ethnicity (Hispanic/Latino 
or non-Hispanic/Latino) of the child.  
Genotyping 
 Genotyping was completed on the Bio-Rad CFX96 real-time PCR machine (Hercules, 
CA) using Life Technologies TaqMan® single nucleotide polymorphism (SNP) genotyping 
assays (LifeTech, Foster City, CA). The singleplex reactions were carried out in 96-well plates 
and used Bio-Rad’s SsoFast™ Probes Supermix as the reaction buffer. PCR amplifications were 
performed using the manufacturer’s suggestion of total volume/well and PCR thermal cycling 
conditions. SNPs of interest are listed in Table I together with their features. SNPs included 
were: established ALL risk markers in previous GWAS, HFE SNPs known to correlate with 
body iron levels, another IRG SNP that shows a very high correlation with serum iron 
parameters in GWAS, and two additional IRG SNPs selected by us as haplotype tag SNPs for the 
promoter regions of two IRGs. We also included three HLA region SNPs known to modify 
lymphoma risk, one being the marker for the HLA-DRB4 lineage 
34
, which is also associated with 
risk for major leukemia types, as previously shown in candidate gene studies 
35-39
. Two 
additional SNPs (rs285 and rs2891) were included as ancestry informative markers (AIMs) for 
statistical adjustment of race/ethnicity as has been used in previous studies of Hispanic 
populations to account for the differences in genetic ancestry 
40, 41
. Bio-Rad CFX Manager 
software (version 3.0) was used for data acquisition and genotype assignment. 
Statistical analysis 
Statistical analyses were performed using Stata v.11 (StataCorp, College Station, TX, 
USA). Logistic regression was used to explore the associations of birth characteristics (birth 
weight, birth length, gestational age) with childhood ALL risk. Linear regression was used to 
assess correlation of genetic markers with continuous birth characteristic variables. The threshold 
for statistical significance was set at P ≤ 0.05, and 95% confidence intervals (CI) of odds ratios 
(OR) were computed. Pearson’s Χ2, Student's t-test (for means) or median test (for medians) 
 were used to compare characteristics between the case and control groups. Genotype counts were 
tested for Hardy–Weinberg equilibrium (HWE) in controls for each SNP (P≤0.001). Correlations 
with genetic markers were assessed using the gene-dosage effect (additive model), which uses all 
three genotypes coded as 0 (wild-type), 1 (heterozygote) and 2 (homozygote) reflecting the 
number of polymorphic allele present in the genotype. For most analyses, cases and controls 
were pooled to increase statistical power, but only after ruling out heterogeneity. As the sample 
was heterogeneous in its ethnic/racial composition, and genetic markers show variation in these 
groups, all results are adjusted for self-declared ethnic/racial groups (coded as non-Hispanic 
Whites, Hispanic Whites, Blacks and others). Since there might still be residual confounding 
after adjustment for self-declared ethnicity/race, we re-examined associations after adjustment 
for two AIMs. 
Results  
Characteristics of the case-control sample are shown in Table II. The case samples 
included 86 males (53%) and 75 females (47%). Out of the cases, 66 identified themselves as 
non-Hispanic White (NHW), 72 as Hispanic White (HW), 17 as Black, and 6 as “other.” The 
“other” group included those identifying themselves as Asian, Native American, or others 
including mixed race/ethnicity. The controls included 130 males (56%) and 101 females (44%), 
who had visited the pediatric clinicfor a non-disease related reason. Forty-nine were classified as 
NHW, 98 as HW, and 78 as Black. The distribution of race and ethnic background was different 
between cases and controls, mainly due to the infrequency of childhood ALL in Blacks. Because 
of this difference, results were adjusted for racial/ethnic background or stratified analyses were 
performed when necessary. The differences in birth characteristics between cases and controls 
are detailed below.  
 Birth weight 
There was no association between childhood ALL and birth weight when the birth weight 
variable was retained as a continuous variable. Since most studies reported a risk association 
with birth weight of 4,000 grams or higher, we categorized the variable as high birth weight 
(≥4,000 g) or others (<4,000 g), and re-examined the association. There was a statistically 
significant association with high birth weight in the overall group (OR = 1.93, 95% CI = 1.16 to 
3.19, P = 0.01, adjusted for self-declared ethnicity/race and gender). Although there was no 
statistical interaction with gender or ethnicity, among the subgroups, the association reached 
statistical significance in males and in Hispanics. The OR was as high as 3.18 (95% CI = 1.16 to 
8.73, P = 0.02) in Hispanic males. The overall association with high birth weight did not change 
when adjusted for each AIM instead of self-declared ethnicity/race. The association with birth 
weight could not be attributed to gestational age heterogeneity, and adjustment for gestational 
age or restriction of the analysis to subjects born at or later than 38 weeks of gestational age did 
not result in a substantial change in the OR of the association. When we categorized the birth 
weight variable into three groups, as customarily done, (<2500g; 2500-3999g; ≥4000g), the 
overall association and association in males remained statistically significant (data not shown).  
Birth length 
As a continuous variable, birth length showed an overall association with childhood ALL 
risk (OR = 1.18 per inch, 95% CI = 1.01 to 1.38, P = 0.04). Among the subgroups, this 
association was statistically significant in females and in non-Hispanic Whites, but there was no 
statistical interaction with gender or ethnicity. In non-Hispanic White females, the OR was 1.81 
(95% CI = 1.03 to 3.18, P = 0.04). Restricting the analysis to subjects born at gestational age 39 
week or later (full-term) did not weaken the results. On the contrary, the OR in the whole group 
 became 1.26 (95% CI = 1.0 to 1.57), and 3.03 (95% CI = 1.19 to 7.74) in non-Hispanic females, 
both remaining statistically significant. 
Gestational age 
In the overall group, there was a risk association with gestational age (OR = 1.10 per 
week, 95% CI = 1.00 to 1.21, P = 0.04, adjusted for ethnicity/race). This association did not 
interact with gender or ethnicity/race although it was stronger in females and in Hispanics with 
the OR reaching 1.43 (95% CI = 1.09 to 1.87, P = 0.009).  
Correlation of birth characteristics with genetic markers 
Having found associations between birth characteristics and childhood ALL risk, we 
sought correlations between the birth characteristics and SNPs included in this study. For these 
analyses, the birth weight variable was used as high birth weight (≥4,000 g) versus others; and 
birth length and gestational age variables were used as continuous variables. Correlations were 
sought in the whole group as well as in the subgroup in which birth characteristics showed the 
strongest leukemia association. We were able to show a correlation for only one genetic marker 
and gestational age. HFE tag SNP rs9366637 showed a significant negative correlation with a 
gene-dosage effect (P=0.005) with gestational age. Males had a stronger negative correlation 
(P=0.001) with this variant. There was no association in females (P=0.98), and the interaction 
with gender reached statistical significance (Pinteraction=0.02). No heterogeneity was found when 
analyzing the case and control groups separately, but the regression coefficients were larger in 
the control group (-0.777 (SE: 0.325) in controls vs. -0.497 (SE: 0.345) in cases). Thus, the 
results were not due to the inclusion of cases in overall analysis. Replacing the self-declared 
ethnicity/race variable with either AIM for adjustment did not alter the results. The average 
gestational age showed a stepwise change with increasing number of rs9366637 variant alleles, 
 with the mean gestational age decreasing from 38.6 weeks (homozygous wild-type) to 36.7 
weeks (homozygous variant) (Figure I, Graph A). 
Because of the known biological relationship between HFE and TFRC 
42, 43
, the 
interaction between TFRC rs3817672 and HFE rs9366637 was assessed. This analysis revealed a 
statistically significant interaction (Pinteraction=0.02) in their association with gestational age. 
Overall, the negative association between rs9366637 and decreasing gestational age increased in 
statistical significance (P=0.001), and the male subgroup again showed the strongest negative 
correlation (P<0.001) in subjects with the particular TFRC genotype. Figure I depicts the mean 
gestational age by HFE rs9366637 and TFRC rs3817672 genotypes. Bar graph A in Figure I 
shows the gestational age means for just the HFE variant on its own, in the overall group. Graphs 
B and C depict the gestational age means for the HFE variant depending on the TFRC genotype 
(AA in Graph B and AG/GG combined in Graph C). Lastly, bar graphs D and E show the mean 
gestational age for males (D) and females (E) who had the HFE and TRFC genotypes that jointly 
showed the strongest correlation with gestational age (Pinteraction = 0.001).  
We also examined the association of the HFE SNP rs9366637 with preterm birth defined 
as gestational age less than 37 weeks. Despite very small number of preterm births in the overall 
sample (n=65), there was an association between this SNP and preterm birth in non-Hispanic 
White males (OR = 5.0, 95% CI = 1.19 to 20.9, P = 0.03), which was due to five of ten preterm 
males being positive for the variant allele of rs9366637.  
Since rs9366637 is a tag SNP, we explored polymorphisms tagged by rs9366637 to see if 
any were functional and/or previously assessed (Table III). We were not able to attribute any 
functionality to any of the tagged SNPs for which rs9366637 is a proxy, despite one having a 
 significant FS score (rs9393682), nor was there any published disease associations with any of 
these SNPs.    
Discussion  
This study observed a birth weight association with childhood ALL risk 
7-9
, and novel 
associations with birth length and gestational age. While birth length association may be due to 
similar mechanisms as the birth weight association, the gestational age association is novel. The 
birth weight association is well known in childhood ALL, and fetal growth rate is probably even 
more crucial 
9
, but we were not able to assess fetal growth rate due to sample size limitations. 
Another novel finding was the inverse correlation between an HFE SNP and gestational age. 
This association showed gender-specificity, gene-dosage effect and a statistical interaction with 
another genotype corresponding to a biological interaction. This is a novel finding worth 
pursuing in future research, as it may lead to development of a marker with some clinical utility.  
The HFE SNP rs9366637 (IVS1) has not been studied as extensively as the other HFE 
variants rs1800562 (C282Y) or rs1799945 (H63D), and has not been directly implicated in iron 
regulation. It has shown a weak correlation with birth weight 
11
. In a case-control study in a Han 
Chinese sample, the variant allele for rs9366637 was also found to be a significant risk marker 
for coronary heart disease (CHD)
44
. The haplotype tagged by this SNP is always devoid of the 
two variants C282Y and H63D that are associated with increased iron levels and presumably, 
also with increased iron placental transfer. 
The inverse correlation found between rs9366637 and gestational age, and its interaction 
with TFRC brings speculation on whether this SNP is also involved in iron homeostasis. There is 
no known effect with this SNP on HFE function, but being positive for this SNP would assure 
the lack of H63D or C282Y on the same chromosome, which may negatively impact placental 
 iron transfer. Thus, if the association of rs9366637 is due to its modification of HFE function, it 
is more likely to be not facilitating iron transfer into the developing fetus.  
The risk association of rs9366627 and coronary heart disease in a Han Chinese 
population where the minor allele frequency is much higher than in European populations may 
be consistent with its association with preterm birth 
44
. Babies born before term are also low birth 
weight and at high risk for cardiovascular diseases later in life 
27
. This issue has been recently 
revisited and nutrition of preterm babies with special formula and accelerated growth in very 
early life have been considered in the pathogenesis of later development of disease in preterm 
babies 
45
. Although our findings are purely statistical correlations, future studies should explore 
potential implications of these findings. 
 We included the interaction analysis of the TFRC variant rs3817672 with HFE variant 
rs9366637 to see if a gene-gene interaction existed. The presence of the TFRC “A” allele was 
associated with increased risk for preterm birth in rs9366637 variant-positive individuals, 
specifically males. Interactions between HFE and TFRC allele “G” have also been noticed in 
various cancers, including multiple myeloma, breast, and colorectal cancer 
42
 as well as 
childhood ALL 
11
. Since the HFE interaction with TFRC allele G is believed to increase 
placental iron transport leading to increased birth weight 
11
 and cancer risk 
46
, it is important to 
note that the interaction of rs9366637 was with TFRC allele A in its association with shorter 
gestational age. This contrast suggests that the inverse correlation with gestational age, if causal, 
is likely to be due to insufficient iron transfer to the fetus, resulting in an iron-deficient 
phenotype. Iron deficiency is indeed a known risk factor for preterm birth 
47
. 
 There were important limitations with our study, including sample size. We were able to 
pool the cases and controls (n=392) to gain statistical power, since cases and controls did not 
 show statistical heterogeneity for the correlation with the HFE SNP. Gestational age was 
provided by the mother of the child enrolled in the study through a questionnaire. Previous 
studies, however, have shown a high correlation between birth weight, gestational ages, and 
other birth characteristics provided by the mother of a patient and medical chart recordings 
17, 48
. 
Non-differential measurement error may have occurred, causing towards-the-null bias, if not all 
gestational ages were correctly recalled. Missing data was another limitation in our study, with 
88% of the total group having gestational age data.  
Results from this study raise an important issue in study designs for future childhood 
studies. Some studies of a childhood disease consist of a control group comprised of full term 
newborns and include as many cases as possible, regardless of their birth term. When this is the 
case, the control group could be missing a whole group of children who may be carriers of 
certain genetic markers. Variants that may be associated with non-term births would be 
eliminated from the control group. The outcome of this mistake could lead to spurious results. 
 In summary, the present study observed associations of birth weight, birth length and 
gestational age with childhood ALL risk, and the HFE variant rs9366637 showed a statistically 
significant negative correlation with gestational age. The SNP rs9366637, which is not known to 
be directly involved with iron homeostasis, showed a positive interaction with a TRFC genotype 
and yielded a stronger association with shorter gestational age, specifically in males. This 
correlation may reveal a connection between altered placental iron transfer and the risk of 
preterm birth. Since our study did not observe other correlations between a number of genetic 
markers and birth characteristics investigated, this may be another area that needs to be 
addressed in larger and more comprehensive studies, ideally using a GWAS design. If our results 
 are validated in different populations, the findings will have implications on iron 
supplementation strategies during pregnancy.
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 Table I. Main features of SNPs analyzed 
Gene SNP 
Chromosome nucleotide 
position
*
 
Minor allele and 
frequency
**
 
SNP Type 
HFE rs1800562 chr6: 26093141 (A) 0.053  Missense  (C282Y) 
HFE rs1799945 chr6: 26091179 (G) 0.179  Missense  (H63D) 
HFE rs9366637 chr6: 26089098 (T) 0.064 Intronic (intron 1) 
TFRC rs3817672 chr3: 195800811 (G) 0.383  Missense (G142S) 
SLC11A1 rs422982 chr12: 51406354 (A) 0.246  Intronic (intron 1) 
TMPRSS6 rs733655 chr22: 37495051 (C) 0.221  Intronic (intron 2) 
TMPRSS6 rs855791 chr22: 37462936 (T) 0.412  Missense (V736A) 
ARID5B rs7089424 chr10: 63752159 (G) 0.314 Intronic (intron 3)  
ARID5B rs10821936 chr10: 63723577 (C) 0.318 Intronic (intron 3) 
ARID5B rs10994982 chr10: 63710104 (A) 0.457 Intronic (intron 3) 
IKZF1 rs4132601 chr7: 50470604 (G) 0.306 3'-UTR 
CEBPE rs2239633 chr14: 23589057 (A) 0.466 5'-upstream 
HLA-DR region rs2395185 chr6: 32433167 (T) 0.423 Intronic 
HLA-DQB1 region rs2647012 chr6: 32664458 (T) 0.381 Intergenic 
HLA-DQA1 region rs10484561 chr6: 32665420 (G) 0.084 Intergenic 
LPL rs285 chr8: 19815189 (T) 0.500  Intronic (intron 6) 
ITGAE rs2891 chr17: 3705526 (G) 0.496  5'-upstream 
 
*Genome Reference Consortium Human Build 37 patch release 10 (GRCh37.p10) used for nucleotide position (http://www.ncbi.nlm.nih.gov/SNP/) 
 
**Minor allele frequencies are from a reference Caucasian population (U.S. residents of northern and western European ancestry) genotyped in HapMap 
project
  
Table II. Characteristics of cases and controls 
  
Cases  
n=161 
Controls 
n=231 
P value 
Ethnic background  
Non-Hispanic White 66  49 
<0.001 
Hispanic White 72 98 
Black 17 78 
Other
*
 6 6 
 
Gender 
Male 86 130 
0.58 Female 75 101 
Ratio 1.15 1.29 
 
Birth weight (grams) 
Mean (SD) 3349.3 (584) 3263.3 (684) 0.23 
Median (IQR) 3400 (760) 3311.5 (850) 0.48 
 
Gestational age (weeks) (SD) 38.8 (2.2) 38.2 (2.8) 0.04 
 
Birth length(cm) (SEM) 51.4 (3.4) 50.1 (5.05) 0.024 
 
 
*Asian, Native American, or other 
  
 
 
 Table III. HFE rs9366637 and SNPs tagged 
 
Proxy Distance r
2*
 Chr. 
Nucleotide 
number 
SNP Location FS score
**
 RegulomeDB
***
 
rs9366637 0 1.00 6 26089098 Intronic 0.208 4 
rs2050947 19019   1.00 6 26070079 Intergenic NA 6 
rs9295682 19604   1.00 6 26069494 Intronic NA NA 
rs9379826 23058   0.89 6 26112156 Intergenic NA 6 
rs9393682 32048   0.89 6 26165029 Intergenic 0.815 4 
 
*
An indication of the correlation with rs9366637; scale of 0-1 with 1 denoting maximum correlation 
** 
FS (functional significance) scores are provided by F-SNP and range from 0 (no tools predict a deleterious effect) to 1 (all tools predict a 
deleterious effect), 
with FS scores ≥0.5 considered significant (http://compbio.cs.queensu.ca/F-SNP) 
***
 RegulomeDB scores range from 1 (most functional) to 5 (least functional) (6=other). Not all SNPs have a RegulomeDB score 
(http://regulome.stanford.edu 
  
  
 
 
 
 
 
Figure I. Gene-gene and gene-gene-gender interactions in gestational age association of 
HFE rs9366637 
A.) Gestational age means in the overall group, depending on the HFE variant 
B.) Gestational age means for the HFE variant and AA TFRC genotype  
C.) Gestational age means for the HFE variant and the AG/GG TFRC genotypes 
D.) Gestational age means for males who had the HFE and TRFC genotypes 
E.) Gestational age means for females who had the HFE and TRFC genotype 
 
 
 
